DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/ths3db\/nanotechnology_for<\/a>) has announced the addition of the \"Nanotechnology for Drug Delivery: Global Market for Nanocrystals\" report to their offering. <\/p>\n Nanocrystals will account for 60% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60\/40 split between nanocrystals and nanocarriers respectively. <\/p>\n Since we now understand that most (if not all) biological processes occur at the nanoscale, the application of life science principles - studying the causes of biological phenomena at the molecular level - means that medical and biomedical research is increasingly using a bottom-up (rather than the top-down) approach. <\/p>\n The healthcare market is changing. The author is seeing a paradigm shift away from blockbusters and a one-size fits all' approach to a more personalised medicine based on an individual's unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become. <\/p>\n Nanocrystals will outperform nanocarriers by 20% <\/p>\n Nanocrystal-based drugs showed the highest market growth in the last decade compared to other nanotechnology-enabled drug delivery systems studied, according to Cientifica Ltd.'s latest research. This is largely due to the shorter development times and smaller investment needed to create nanocrystals. The report presents a detailed discussion of recent developments (2000-2010) in nanocrystal therapies and future opportunities (2011-2021). <\/p>\n The low bioavailability resulting from traditional oral (both tablet and liquid) drug delivery methods and the market forces at work in the pharmaceutical industry - where patents expire after a relatively short period of time unless a novel form of drug delivery is developed that will extend the patent - are two major forces that will fuel the growth of the nanotech enabled drug delivery market, said Harper. <\/p>\n The National Science Foundation has forecast the global nanotech-enabled market will reach US$1 trillion by 2015, while the National Nanotechnology Initiative predicts it will reach US$3 trillion by 2020. Drug nanocrystals would therefore account for approximately 2.5% of the total global nanotechnology market in 2015 and 3.5% in 2021. <\/p>\n For more information visit http:\/\/www.researchandmarkets.com\/research\/ths3db\/nanotechnology_for<\/a> <\/p>\n<\/p>\n View original post here: DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/ths3db\/nanotechnology_for<\/a>) has announced the addition of the \"Nanotechnology for Drug Delivery: Global Market for Nanocrystals\" report to their offering. Continue reading
\nResearch and Markets: Nanotechnology for Drug Delivery: Global Market for Nanocrystals - Drug Nanocrystal Market Will ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"